Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Journal of Hematopathology|August 12, 2009
Prognostic impact of C-REL expression in diffuse large B-cell lymphomaCholadda V Curry, April A Ewton, Randall J Olsen, et al.
Blood Advances|July 27, 2019
Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantationEdmund K Waller, Brent R Logan, Mingwei Fei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2015
Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research StudyMohamed L Sorror, Brent R Logan, Xiaochun Zhu, et al.
Blood Advances|January 7, 2026
Validated Clinical Risk Score for Acute Graft-Versus-Host Disease in Adult Allogeneic Hematopoietic Cell TransplantationCaden Ulschmid, Xiao Li, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2016
Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201Linda J Burns, Brent R Logan, Pintip Chitphakdithai, et al.
Blood|March 3, 2012
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network studyJohn E Levine, Brent R Logan, Juan Wu, et al.
Blood|May 19, 2012
A perspective on the selection of unrelated donors and cord blood units for transplantationStephen R Spellman, Mary Eapen, Brent R Logan, et al.
The Journal of Clinical Investigation|August 1, 2023
Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and deathBrent R Logan, Denggang Fu, Alan Howard, et al.
Blood|July 18, 2009
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell doseMichael A Pulsipher, Pintip Chitphakdithai, Brent R Logan, et al.
Blood Advances|April 10, 2023
Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemicSteven M Devine, Stephanie Bo-Subait, Michelle Kuxhausen, et al.
Pageof 20